Spraysel odobren v Rossii dlya vzroslykh patsientovs vpervye vyyavlennym khronicheskim mieloidnym leykozom (KhML)
Main Author: | - - |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2011-03-01
|
Series: | Современная онкология |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/29420 |
Similar Items
-
Tasigna odobrena v Rossiidlya lecheniya vzroslykh patsientovs vpervye vyyavlennym khronicheskimmieloidnym leykozom (KhML)
by: - -
Published: (2011-09-01) -
Preparat Gaziva® stanet dostupen dlya terapii patsientov s khronicheskim limfotsitarnym leykozom
by: - -
Published: (2015-06-01) -
Prediktory angiopatiy u patsientov s narushennoy tolerantnost'yu k glyukoze i vpervye vyyavlennym sakharnym diabetom 2 tipa
by: I A Romanenko, et al.
Published: (2005-06-01) -
Press-reliz Preparat Avastin® odobren v Rossii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom v 1 i 2-y liniyakh terapii nepreryvno
by: - -
Published: (2013-09-01) -
Vliyanie T-aktivina na pokazateli kletochnogo zvena immuniteta u bol'nykh s vpervye vyyavlennym sakharnym diabetom 1 tipa
by: V I Novikov
Published: (1999-12-01)